2023. Efficacy of Empagliflozin versus Dapagliflozin in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Trial. Global journal of medical and pharmaceutical sciences. 1, 3 (Oct. 2023), 09–16.